Amneal Pharmaceuticals, Inc. (AMRX)

Every FINRA and SEC series the site collects for Amneal Pharmaceuticals, Inc.: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on Nasdaq.

Download CSV

9.5M

Short interest

settlement 2026-08-14

4.9

Days to cover

+14.3% vs prior

60.5%

Short share of volume

2026-09-11

191

Fails to deliver

settlement 2026-08-13

-$7.2M

Insider flow, 90 days

0 buys, 4 sells

As of 2026-09-11.

Short interest

FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSON

As of 14 August 2026, short interest in AMRX is 9,514,369 shares, up 1,395,670 shares over the last month. Over the last 48 readings it ranged from 2,421,354 shares (31 January 2025) to 12,685,342 shares (30 January 2026). At the reported average volume of 1.9M shares a day that is 4.9 days to cover.

Embed this chartfree, with the attribution line it carries

<iframe src="https://xoomar.com/embed/stocks/amrx" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

Preview Dark previewAdd ?theme=dark to the src for a dark chart.

Settlement	Shares short	Change	Avg daily volume	Days to cover
2026-08-14	9,514,369	+14.3%	1,947,571	4.89
2026-07-31	8,320,187	+2.5%	1,821,920	4.57
2026-07-15	8,118,699	+3.6%	1,803,546	4.50
2026-06-30	7,835,011	-1.1%	2,711,732	2.89
2026-06-15	7,918,225	+5.1%	2,038,855	3.88
2026-05-29	7,531,025	-5.5%	1,624,634	4.64
2026-05-15	7,964,885	-30.8%	1,475,153	5.40
2026-04-30	11,507,430	+34.5%	1,756,888	6.55
2026-04-15	8,556,479	+18.9%	1,392,898	6.14
2026-03-31	7,193,959	-33.6%	2,124,225	3.39
2026-03-13	10,840,612	+9.3%	2,406,067	4.51
2026-02-27	9,920,253	-6.4%	1,888,990	5.25
2026-02-13	10,600,098	-16.4%	2,056,078	5.16
2026-01-30	12,685,342	+87.3%	5,603,339	2.26
2026-01-15	6,772,644	-1.1%	1,516,619	4.47
2025-12-31	6,851,192	+28.4%	1,852,007	3.70
2025-12-15	5,336,430	-12.8%	1,873,896	2.85
2025-11-28	6,119,022	-6.9%	1,590,659	3.85
2025-11-14	6,575,260	+17.9%	2,083,045	3.16
2025-10-31	5,577,526	-3.1%	1,467,252	3.80
2025-10-15	5,754,980	+1.1%	1,556,077	3.70
2025-09-30	5,694,704	+12.8%	1,863,435	3.06
2025-09-15	5,048,582	-1.2%	1,564,764	3.23
2025-08-29	5,109,400	+6.9%	1,413,863	3.61

Daily short volume

FINRA Reg SHO, last 60 sessions. JSON

As of 11 September 2026, the short share of AMRX volume is 60.5%, up 6.9 points over the last five sessions. Over the last 52 readings it ranged from 30.6% (13 July 2026) to 81.9% (23 July 2026). The latest reading is in line with the 30-session average of 60.3%, on 425K shares reported.

Date	Short volume	Total volume	Short share	Exempt
2026-09-11	257K	425K	60.5%	0
2026-09-10	276K	416K	66.2%	0
2026-09-09	342K	504K	67.9%	0
2026-09-08	289K	569K	50.8%	0
2026-09-04	311K	518K	60.1%	100
2026-09-03	453K	845K	53.6%	0
2026-09-02	453K	1.0M	44.1%	0
2026-09-01	282K	441K	63.8%	0
2026-08-31	325K	471K	68.9%	40
2026-08-28	312K	475K	65.6%	0
2026-08-27	262K	344K	76.3%	0
2026-08-26	209K	341K	61.3%	0
2026-08-25	228K	432K	52.8%	0
2026-08-24	277K	434K	63.8%	0
2026-08-21	201K	379K	53.1%	0
2026-08-20	205K	361K	56.8%	20
2026-08-19	275K	577K	47.6%	0
2026-08-18	466K	792K	58.9%	0
2026-08-17	455K	655K	69.5%	0
2026-08-14	551K	867K	63.5%	0
2026-08-13	710K	1.0M	70.8%	4,756
2026-08-12	468K	851K	55.0%	235
2026-08-11	422K	745K	56.7%	319
2026-08-10	285K	441K	64.6%	86
2026-08-07	231K	387K	59.9%	0
2026-08-06	317K	491K	64.5%	0
2026-08-05	313K	476K	65.6%	0
2026-08-04	454K	659K	69.0%	3,763
2026-08-03	535K	898K	59.6%	0
2026-07-31	300K	782K	38.4%	0

Fails to deliver

SEC, by settlement date. JSON

As of 13 August 2026, the fails-to-deliver balance in AMRX is 191 shares, down 13,284 shares over the last settlement date. Over the last 23 readings it ranged from 1 share (7 April 2026) to 252,180 shares (12 September 2025). The latest reading sits at the bottom of that range.

Settlement	Shares failed	Price	Value
2026-08-13	191	$17.66	$3K
2026-07-21	13,475	$17.50	$236K
2026-07-16	523	$17.20	$9K
2026-07-01	1,754	$17.31	$30K
2026-06-18	25	$16.28	$407
2026-06-15	6	$16.20	$97
2026-06-12	1,402	$16.34	$23K
2026-06-10	4,720	$14.69	$69K
2026-04-07	1	$12.35	$12
2026-03-23	84	$11.83	$994
2026-03-13	439	$12.12	$5K
2026-02-27	320	$14.49	$5K
2026-02-05	617	$14.43	$9K
2026-02-03	38,390	$14.19	$545K
2026-01-08	581	$13.26	$8K
2025-12-22	1,822	$12.57	$23K
2025-12-10	41	$11.97	$491
2025-10-14	200	$9.75	$2K
2025-09-24	8	$9.84	$79
2025-09-17	53	$9.74	$516
2025-09-16	97,602	$9.79	$956K
2025-09-15	97,603	$10.00	$976K
2025-09-12	252,180	$10.09	$2.5M

Insider trades

SEC Form 4, newest first. JSON

Insiders at AMRX reported 4 open-market sells worth $7.2M in the last 90 days and no open-market buys. Sells alone are a weak signal; insiders sell for tax, diversification and estate reasons all the time. Latest filing: BOYER ANDREW S (Executive Vice President) on 2026-09-01.

Date	Insider	Title	Type	Shares	Price	Value	Owned after
2026-09-01	BOYER ANDREW S	Executive Vice President	Gift	80K	$0.00	$0	194K
2026-08-21	BOYER ANDREW S	Executive Vice President	Gift	152K	$0.00	$0	274K
2026-08-13	Kiely John	n/a	Gift	10K	$0.00	$0	200K
2026-08-13	Kiely John	n/a	Sell	50K	$17.64	$882K	210K
2026-08-12	Shah Nikita	Executive Vice President	Sell	146K	$17.51	$2.6M	253K
2026-08-12	Daly Jason B.	EVP, Chief Legal Officer	Sell	210K	$17.40	$3.7M	35K
2026-08-11	Daly Jason B.	EVP, Chief Legal Officer	Sell	7K	$17.70	$117K	245K
2026-08-11	BUCHI J KEVIN	n/a	Option exercise	169K	$17.18	$2.9M	93K
2026-05-11	Autor Deborah M.	n/a	Sell	35K	$12.94	$451K	94K
2025-11-17	Nark Ted C	n/a	Sell	50K	$11.72	$586K	291K
2025-11-12	Shah Nikita	Executive Vice President	Sell	132K	$11.92	$1.6M	146K
2025-11-12	Shah Nikita	Executive Vice President	Option exercise	96K	$2.75	$263K	278K
2025-11-12	Shah Nikita	Executive Vice President	Option exercise	36K	$2.75	$100K	183K
2025-08-27	Kiely John	n/a	Sell	32K	$9.23	$295K	225K
2025-08-25	Shah Nikita	Executive Vice President	Sell	6K	$9.50	$60K	146K
2025-08-22	Shah Nikita	Executive Vice President	Sell	114K	$9.66	$1.1M	153K
2025-08-20	BOYER ANDREW S	Executive Vice President	Sell	279K	$9.38	$2.6M	152K
2025-08-20	BOYER ANDREW S	Executive Vice President	Option exercise	175K	$2.75	$481K	432K
2025-08-15	Konidaris Tasos	Executive Vice President & CFO	Sell	219K	$9.43	$2.1M	122K
2025-08-14	Shah Nikita	Executive Vice President	Sell	72K	$9.29	$666K	267K
2025-08-14	Konidaris Tasos	Executive Vice President & CFO	Sell	119K	$9.30	$1.1M	341K
2025-08-13	Konidaris Tasos	Executive Vice President & CFO	Sell	161K	$9.22	$1.5M	461K
2025-08-12	Shah Nikita	Executive Vice President	Sell	50K	$9.04	$452K	339K
2025-08-12	Daly Jason B.	EVP, Chief Legal Officer	Sell	22K	$9.05	$199K	11K
2025-08-12	BOYER ANDREW S	Executive Vice President	Sell	33K	$9.05	$303K	257K
2025-06-16	Patel Gautam	n/a	Sell	95K	$8.02	$761K	1.6M
2025-06-10	Patel Gautam	n/a	Sell	56K	$8.02	$453K	1.7M

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.

Planned sales (Form 144)

Newest first. JSON

1 Form 144 notice on file for AMRX worth $2.9M at the prices reported; 1 in the last 90 days worth $2.9M. Latest: BUCHI J KEVIN filed on 2026-08-11 to sell 168,573 shares ($2.9M) from 2026-08-11.

Filed	Seller	Shares	Market value	Of outstanding	Sale from	Broker
2026-08-11	BUCHI J KEVINDirector	169K	$2.9M	0.053%	2026-08-11	Charles Schwab Corp

Large holders (13D and 13G)

One row per reporting person, newest filing first. JSON

3 holders above 5% have filed on AMRX, 3 on Schedule 13D (active intent). The largest reported stake is Tushar Patel at 17.6% of the class (61,341,678 shares), filed 2026-08-12 for an event on 2026-08-10.

Filed	Form	Holder	Shares	Of class	Event
2026-08-12	13D/Ano. 6	Tushar Patelindividual	61.3M	17.6%	2026-08-10
2026-08-12	13D/Ano. 5	Chintu Patelindividual	32.6M	9.4%	2026-08-10
2026-08-12	13D/Ano. 7	Chirag Patelindividual	29.1M	8.4%	2026-08-10

13F holders

Tracked managers holding AMRX at their latest 13F. JSON

6 of the 30 tracked managers held AMRX at their latest 13F, $52.8M in total at quarter-end prices. Citadel Advisors is the largest at $19.9M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 1 added shares and 4 cut.

Fund	Quarter	Shares	Value	Of portfolio	Change in shares
Citadel Advisors	2026-06-30	1.1M	$19.9M	0.00%	+529K
AQR Capital Management	2026-06-30	795K	$13.8M	0.00%	-70K
D. E. Shaw & Co.	2026-06-30	774K	$13.4M	0.01%	-946K
Two Sigma Investments	2026-06-30	233K	$4.0M	0.00%	-49K
Renaissance Technologies	2026-06-30	87K	$1.5M	0.00%	-189K
Millennium Management	2026-06-30	15K	$256K	0.00%	new or n/a

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

Amneal Pharmaceuticals, Inc. in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.

This page follows Amneal Pharmaceuticals, Inc. (AMRX), SEC CIK 1723128, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.

Source and method

Short interest: FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-14.JSON and CSV
Daily short volume: FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-11.JSON and CSV
Fails to deliver: SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-13.JSON and CSV
Planned sales: SEC EDGAR Form 144EDGAR read every 30 minutes; a notice is filed on or before the sell order. Latest 2026-08-11.JSON and CSV
Large holders: SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-08-12.JSON and CSV
13F holders: SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Insider trades: SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-09-01.JSON and CSV
Company record: EDGAR filing index for CIK 1723128Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits: 30 requests a minute without a key, 120 a minute with a key from a free account.

Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 13 Sep 05:40 UTC.

How to read it

Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of AMRX is sold short?

9,514,369 shares were held short at the 2026-08-14 settlement, 4.9 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.

What is AMRX's daily short volume?

On 2026-09-11, 256,712 of the 424,532 AMRX shares reported to FINRA were sold short, 60.5% of the day's reported volume. Short volume is a flow for one day, not a position.

Does AMRX have fails to deliver?

The SEC's latest file shows 191 AMRX shares failed to deliver at settlement 2026-08-13. Fails are reported per settlement date and published twice a month with a lag.

Are AMRX insiders buying or selling?

Have AMRX insiders filed to sell?

1 Form 144 notice on file for AMRX worth $2.9M at the prices reported; 1 in the last 90 days worth $2.9M. Latest: BUCHI J KEVIN filed on 2026-08-11 to sell 168,573 shares ($2.9M) from 2026-08-11.

Who owns more than 5% of AMRX?

Which funds hold AMRX?

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.

Amneal Pharmaceuticals, Inc. (AMRX)

Short interest

Daily short volume

Fails to deliver

Insider trades

Planned sales (Form 144)

Large holders (13D and 13G)

13F holders

Amneal Pharmaceuticals, Inc. in the regulatory record

Source and method

How to read it

Other company pages

Datasets

Frequently Asked Questions